News
39m
AstraZeneca Plc (NASDAQ:AZN) released high-level results from the Cardiac Amyloid Reaching for Extended Survival (CARES) ...
The CARES clinical programme is the largest prospective investigation in cardiac AL amyloidosis to date with a total of 406 patients enrolled from 19 countries globally, including 281 patients with ...
New program combines IV-delivered TRACERâ„¢ capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delivering the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback